Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen M Blake

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Current Opinion in Nephrology and Hypertension|October 24, 2002
Bone densitometry, steroids and osteoporosisGlen M Blake, Ignac Fogelman
BMJ (Clinical Research Ed.)|June 18, 2005
Strontium ranelate for the treatment of osteoporosisIgnac Fogelman, Glen M Blake
Clinical Interventions in Aging|December 1, 2007
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacyGlen M Blake, Ignac Fogelman
Lancet (London, England)|December 20, 2005
Bone densitometry: an updateIgnac Fogelman, Glen M Blake
Seminars in Nuclear Medicine|December 5, 2009
An update on dual-energy x-ray absorptiometryGlen M Blake, Ignac Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 10, 2007
Effect of bone strontium on BMD measurementsGlen M Blake, Ignac Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 24, 2012
Can dual-energy x-ray absorptiometry-based hip structural analysis be used in patients treated with strontium ranelate?Glen M Blake, Ignac Fogelman
Nature Reviews. Endocrinology|October 23, 2013
Bone: Strontium ranelate does not have an anabolic effect on boneGlen M Blake, Ignac Fogelman
Seminars in Musculoskeletal Radiology|January 24, 2003
Dual energy x-ray absorptiometry and its clinical applicationsGlen M Blake, Ignac Fogelman
Calcified Tissue International|July 8, 2005
Fracture prediction by bone density measurements at sites other than the fracture site: the contribution of BMD correlationGlen M Blake, Ignac Fogelman
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Current Opinion in Nephrology and Hypertension|October 24, 2002
Bone densitometry, steroids and osteoporosisGlen M Blake, Ignac Fogelman
BMJ (Clinical Research Ed.)|June 18, 2005
Strontium ranelate for the treatment of osteoporosisIgnac Fogelman, Glen M Blake
Clinical Interventions in Aging|December 1, 2007
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacyGlen M Blake, Ignac Fogelman
Lancet (London, England)|December 20, 2005
Bone densitometry: an updateIgnac Fogelman, Glen M Blake
Seminars in Nuclear Medicine|December 5, 2009
An update on dual-energy x-ray absorptiometryGlen M Blake, Ignac Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 10, 2007
Effect of bone strontium on BMD measurementsGlen M Blake, Ignac Fogelman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 24, 2012
Can dual-energy x-ray absorptiometry-based hip structural analysis be used in patients treated with strontium ranelate?Glen M Blake, Ignac Fogelman
Nature Reviews. Endocrinology|October 23, 2013
Bone: Strontium ranelate does not have an anabolic effect on boneGlen M Blake, Ignac Fogelman
Seminars in Musculoskeletal Radiology|January 24, 2003
Dual energy x-ray absorptiometry and its clinical applicationsGlen M Blake, Ignac Fogelman
Calcified Tissue International|July 8, 2005
Fracture prediction by bone density measurements at sites other than the fracture site: the contribution of BMD correlationGlen M Blake, Ignac Fogelman
Pageof 16